Heterologous vaccine regimens against COVID-19

被引：29
|
作者：
Duarte-Salles, Talita [1 ]
Prieto-Alhambra, Daniel [2 ,3 ]
机构：
[1] Fundacio Inst Univ Recerca Atencio Primaria Salud, Barcelona 08007, Spain
[2] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[3] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands
来源：
LANCET | 2021年 / 398卷 / 10295期
关键词：
D O I：
10.1016/S0140-6736(21)01442-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：94 / 95
页数：2
相关论文
共 50 条
  • [41] Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens
    Kanokudom, Sitthichai
    Chansaenroj, Jira
    Suntronwong, Nungruthai
    Assawakosri, Suvichada
    Yorsaeng, Ritthideach
    Nilyanimit, Pornjarim
    Aeemjinda, Ratchadawan
    Khanarat, Nongkanok
    Vichaiwattana, Preeyaporn
    Klinfueng, Sirapa
    Thongmee, Thanunrat
    Katanyutanon, Apirat
    Thanasopon, Wichai
    Arayapong, Jirawan
    Withaksabut, Withak
    Srimuan, Donchida
    Thatsanatorn, Thaksaporn
    Sudhinaraset, Natthinee
    Wanlapakorn, Nasamon
    Honsawek, Sittisak
    Poovorawan, Yong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 126 : 64 - 72
  • [42] Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
    Park, Seon Kyeong
    Choe, Young June
    Jang, Eun Jung
    Kim, Ryu Kyung
    Lee, Sang-Won
    Kwon, Geun-Yong
    Shin, Jeeyeon
    Choi, Sang-Yoon
    Jeong, Mi Jin
    Park, Young-Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (19)
  • [43] Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
    Hill, Joshua A.
    Ujjani, Chaitra S.
    Greninger, Alexander L.
    Shadman, Mazyar
    Gopal, Ajay K.
    CANCER CELL, 2021, 39 (08) : 1037 - 1038
  • [44] Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
    Thuy Trang Nguyen
    Trang Ho Thu Quach
    Thanh Mai Tran
    Huynh Ngoc Phuoc
    Ha Thi Nguyen
    Tuong Kha Vo
    Giau Van Vo
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [45] A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization
    Mattoo, Sameer-ul-Salam
    Myoung, Jinjong
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 31 (12) : 1601 - 1614
  • [46] Emerging evidence on heterologous COVID-19 vaccine schedules-to mix or not to mix?
    Parker, Edward P. K.
    Desai, Shalini
    Marti, Melanie
    O'Brien, Katherine L.
    Kaslow, David C.
    Kochhar, Sonali
    Olayinka, Folake
    Cravioto, Alejandro
    Nohynek, Hanna
    Hombach, Joachim
    Wilder-Smith, Annelies
    LANCET INFECTIOUS DISEASES, 2022, 22 (04): : 438 - 440
  • [47] Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore
    Tan, Sharon Hui Xuan
    Pung, Rachael
    Wang, Lin-Fa
    Lye, David Chien
    Ong, Benjamin
    Cook, Alex R.
    Tan, Kelvin Bryan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (12): : 1181 - 1182
  • [48] Expected Usefulness of Fourth Dose of COVID-19 Vaccine for Patients with Underlying Solid Tumor who Previously Received the Primary Heterologous COVID-19 Vaccine
    Yasri, Sora
    Wiwanitkit, Viroj
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2024, 45 (04) : 301 - 305
  • [49] Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis
    Zhang, Xiaoyin
    Xia, Jiayue
    Jin, Lairun
    Wu, Yanfei
    Zheng, Xiuyu
    Cao, Xiang
    Meng, Xingchen
    Li, Jingxin
    Zhu, Fengcai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [50] Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
    Luvira, Viravarn
    Pitisuttithum, Punnee
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 283 - 293
12345